US 10357539
Use of peptides that block metadherin-SND1 interaction as treatment for cancer
granted A61KA61K38/08A61K38/10
Quick answer
US patent 10357539 (Use of peptides that block metadherin-SND1 interaction as treatment for cancer) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE TRUSTEES OF PRINCETON UNIVERSITY
- Grant date
- Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/08, A61K38/10, A61K38/1709, A61P